Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-006548
Filing Date
2022-01-21
Accepted
2022-01-21 17:54:23
Documents
1
Period of Report
2022-01-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm224209-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm224209-1_4seq1.xml 4 3458
  Complete submission text file 0001104659-22-006548.txt   4849
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Issuer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
MCCOURT Thomas A (Reporting) CIK: 0001478448 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34620 | Film No.: 22546947